We harness the power of artificial intelligence, advanced wet lab techniques and expert creativity to transform areas of significant value in biologics discovery and engineering.
AI-designed large-scale GPCR mutagenesis to deliver the best antigen for antibody discovery
Enabling rapid antibody discovery in the untapped GPCR target space
Parallel super humanization, developability optimization, and pH sensitivity engineering
Variants
Expressed
Weeks
Objectives Achieved Simultaneously
Fold pH Sensitivity
2candidates
In silico workflow
In vitro workflow
1 candidate
16 His mut sites
216 Yeast library
15 expressed
28 expressed
1 top variant
1 top variant
1 combined variant
AI-powered hit selection and amplification from immune repertoire sequencing
Rounds
Expressed
Function Hits
Activity Span
Weeks
Integrates fully with conventional discovery and engineering
Â
The future of biotechnology is collaborative. We believe the best solutions come from working together with companies and researchers who share our vision. Are you ready to push the boundaries of what’s possible?
Copyright 2024 @ Ailux Biologics. All rights reserved.